Apéndices

I. Composición del Corpus

II. Lista de Frecuencias

1. Apéndice II a: 1-1219
2. Apéndice II b: 1220-2438
3. Apéndice II c: 2438-3595
4. Apéndice II d: 3596-4814
5. Apéndice II e: 3596-6033
6. Apéndice II f: 6034-7252
7. Apéndice II g: 7253-8410
8. Apéndice II h: 8411-9642

III. Clusters de la cadena léxica HAVE-NEOPLASM

1. Cancer
2. Tumor
3. Disease
4. Carcinoma
5. Metastases
6. Leukemia
7. Lymphoma
8. Sarcoma
9. Melanoma
10. Adenocarcinoma
11. Rhabdomyosarcoma
12. Mass
13. Glioma
14. Malignancy
15. Astrocytoma
16. Neoplasm
17. Neuroblastoma
18. Myeloma
19. Ependyoma
20. Osteosarcoma
21. Medulloblastoma
22. Pheochromocytoma
23. Retinoblastoma
24. Hepatoblastoma
25. Seminoma
26. Teratoma
27. Nonseminoma
28. Mesothelioma
29. Thymoma
30. Neoplasia
31. Dysgerminoma
32. Meningioma
33. Adenoma
34. Pineoblastoma
35. Plasmacytoma
36. Nonrhabdomyosarcoma
37. Leiomyosarcoma
38. Oligodendroglioma
39. Germinoma
40. Hepatoma
41. Papilloma
42. Ganglioglioma
43. Histocytoma
44. Fibrosarcoma
45. Cholangiocarcinoma
46. Glioblastoma
47. Insulinoma
48. Gastrinoma
49. Granuloma
50. Chondrosarcoma
51. Ependymoblastoma
52. Cystadenomas
53. Erythrole)ukemia
54. Chorioadenoma
55. Nephroblastoma
56. Erythroplasia
57. Mesenchymoma
58. Neuropithelioma

IV. Esquemas frasémicos de la categoría HAVE-NEOPLASM y TUMOR

• EVENT_relation_OBJECT

  • HAVE-NEOPLASM_location (event-state-relation: case-role)_BODY-PART
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_PHYSIOLOGICAL-SYSTEM
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_TISSUE
    • HAVE-NEOPLASM_location (event-state-relation: case-role)_CELL
  • HAVE-NEOPLASM_affects-body-part (disease-event-object-relation)_BODY-PART
  • HAVE-NEOPLASM_experiencer (event-state-relation: case-role)_PATIENT
  • HAVE-NEOPLASM_treated-with-the-use-of (disease-event-object-relation)_DRUG
  • HAVE-NEOPLASM_metastatizes-to (disease-event-object-relation)_BODY-PART
  • HAVE-NEOPLASM_origin (event-object-relation)_BODY-PART
• EVENT_relation_EVENT
  • HAVE-NEOPLASM_caused-by (event-state-relation: condition-of-change)_DISEASE-EVENT
  • HAVE-NEOPLASM_diagnosed-with (disease-event-relation)_DIAGNOSTIC-TEST
  • HAVE-NEOPLASM_treated-with (disease-event-relation)_TREATMENT
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_CHEMOTHERAPY
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_SURGICAL-PROCEDURE
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_RADIOTHERAPY
    • HAVE-NEOPLASM_treated-with (disease-event-relation)_ADJUVANT-THERAPY
  • HAVE-NEOPLASM_theme-of (inverse-event-state-relation: inverse-case-role)_MEDICAL-SERVE
  • HAVE-NEOPLASM_theme-of (inverse-event-state-relation: inverse-case-role)_PHYSICAL-EVENT
  • HAVE-NEOPLASM_has-symptom (disease-event-relation)_DISEASE-EVENT
  • HAVE-NEOPLASM_has-risk-factor (disease-event-relation)_LIVING-EVENT
  • HAVE-NEOPLASM_has-prognostic-factor_(disease-event-relation)_LIVING-EVENT
  • HAVE-NEOPLASM_responds-to (disease-event-relation)_TREATMENT
• EVENT_ATTRIBUTE
  • HAVE-NEOPLASM_tumor-condition (literal-disease-event-attribute): benign/borderline/malignant
  • HAVE-NEOPLASM_invasive-attirbue (literal-disease-event-attribute): preinvasive/invasive/non-invasive
  • HAVE-NEOPLASM_tumor-site-attirbute (literal-disease-event-attribute): primary/secondary/residual
  • HAVE-NEOPLASM_primary-site-attribute (binary-disease-event-attribute): known/unknown
  • HAVE-NEOPLASM_primary-tumor-number (literal-disease-event-attribute): first/second
  • HAVE-NEOPLASM_affected-population-age (literal-disease-event-attribute): adult/child
  • HAVE-NEOPLASM_affected-population-age-sex (literal-disease-event-attribute): male/female
  • HAVE-NEOPLASM_diagnosis (literal-disease-event-attribute): name of disease
  • HAVE-NEOPLASM_prognosis-attribute (literal-disease-event-attribute): poor/medium/favorable
  • HAVE-NEOPLASM_treatement-attribute (binary-disease-event-attribute): treated/untreated
  • HAVE-NEOPLASM_metastatic-attribute (binary-disease-event-attribute): metastatic/non-metastatic
  • HAVE-NEOPLASM_risk-factors-evaluation (binary-disease-event-attribute): good/bad
  • HAVE-NEOPLASM_prognostic-factors-evaluation (literal-disease-event-attribute): poor/medium/favourable
  • HAVE-NEOPLASM_clinical-manifestations (binary-disease-event-attribute): symptomatic/asymptomatic
  • HAVE-NEOPLASM_time-science (binary-event-attribute): synchronous/metachronous
  • HAVE-NEOPLASM_genetic-susceptibility (binary-disease-event-attribute): familial / sporadic
  • HAVE-NEOPLASM_laterality (literal-disease-event-attribute): unilateral/bilateral/trilateral
  • HAVE-NEOPLASM_mortality-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_mortality-rate (literal-disease-event-attribute): low/high
  • HAVE-NEOPLASM_disease-survival (literal-disease-event-attribute): disease-free/overall
  • HAVE-NEOPLASM_survival-duration (scalar-disease-event-attribute): number of years
  • HAVE-NEOPLASM_survival-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_survival-rate (literal-disease-event-attribute): low/ high
  • HAVE-NEOPLASM_risk-rate (scalar-event-attribute): %
  • HAVE-NEOPLASM_risk-rate (literal-event-attribute): high/low
  • HAVE-NEOPLASM_frequency-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_frequency-rate (literal-disease-event-attribute): high/ low
  • HAVE-NEOPLASM_risk-potential (literal-disease-event-attribute): high/intermediate/low
  • HAVE-NEOPLASM_progression-attribute (binary-disease-event-attribute): stable/progressive
  • HAVE-NEOPLASM_progress-rate (literal-disease-event-attribute): slow/rapid
  • HAVE-NEOPLASM_responsiveness (literal-disease-event-attribute): complete response/ partial response/ no response
  • HAVE-NEOPLASM_response-sequence (literal-disease-event-attribute): first/second
  • HAVE-NEOPLASM_response-time (literal-disease-event-attribute): slow/rapid
  • HAVE-NEOPLASM_response-duration (literal-disease-event-attribute): transient/durable
  • HAVE-NEOPLASM_response-duration (scalar-disease-event-attribute): number of months/ years
  • HAVE-NEOPLASM_response-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_response-rate (literal-disease-event-attribute): high/low
  • HAVE-NEOPLASM_curability (binary-disease-event-attribute): curable/incurable
  • HAVE-NEOPLASM_curability-rate (scalar-disease-event-attribute): %
  • HAVE-NEOPLASM_curability-rate (literal-disease-event-attribute): high/medium/low
  • HAVE-NEOPLASM_cancer-staging
    • HAVE-NEOPLASM_TNM-classification (literal-disease-event-attribute): T (X,0,IS,1,1A,1B,1C,2,2A,2B,2C,3, 3A,3B,3CY,4,4A,4B,4C,4D) N (X,0,1,2,3) M (X,0,1)
    • HAVE-NEOPLASM_stage-classification (literal-disease-event-attribute): early/advanced, 0/I (A,B)/II (A,B)/III (A,B)/IV (A,B,S)/V, A/B1/B2/B3/C1/C2/C3, A/A1/A2/B/C/D/D1/D2, chronic phase/accelerated phase/blastic phase
    • HAVE-NEOPLASM_extent-classification (literal-disease-event-attribute): localized/non-localized
    • HAVE-NEOPLASM_invasiveness-classification (literal-disese-event-attribute): deep/superficial
• OBJECT_ATTRIBUTE
  • TUMOR_size (scalar-physical-object-attribute): > 0
  • TUMOR_size (literal-physical-object-attribute): small / medium/large
  • TUMOR_amount (binary-tumor-attribute): single/multiple
  • TUMOR_palpability-attribute (binary-tumor-attribute): palpable/non-palpable
  • TUMOR_tumor-consistency (literal-tumor-attribute): solid/serous
  • TUMOR_resectability (binary-tumor-attribute): resectable/non-resectable
  • TUMOR_secretion (binary-tumor-attribute): secreting/non-secreting
  • TUMOR_histological-composition (literal-tumor-attribute): mixed/pure
  • TUMOR_histology-evaluation (binary-tumor-attribute): favorable/unfavorable
  • TUMOR_tumor-garding
    • TUMOR_tumor-degree-of-differentiation (literal-tumor-attribute): well differentiated/moderately differentiated/poorly differentiated/undifferentiated
    • TUMOR_histologic-tumor-grade (scalar-tumor-attribute): I/II/III/IV
    • TUMOR_histologic-tumor-grade (literal-tumor-attribute): high/medium/low
    • TUMOR_malignancy-potential (literal-tumor-attribute): low/borderline/high